ClearPoint Neuro, Inc. (CLPT): who owns it and who trades it
As of Nov 16, 2026, CLPT insiders reported 9 open-market sales worth $2.5M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Joseph Burnett (CEO), with $2.2M. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling ClearPoint Neuro
From the latest filingsOverall: more selling than buying. Insiders mostly sold. Funds mostly bought. Famous investors was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns CLPT
129 funds and institutions reported CLPT shares worth $249M at the end of Q2 2026, about 47% of the company. The largest holder is BlackRock, Inc. with 8.0%.
Funds and institutions (13F) 47%Everyone else 53%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 2.38M | 8.02% | $42.5M | +14% |
| Mak Capital One LLC | 2.38M | 8.01% | $42.4M | +25% |
| Vanguard Capital Management LLC | 1.23M | 4.16% | $22M | -1% |
| State Street Corp | 816,547 | 2.75% | $14.6M | +20% |
| Geode Capital Management, LLC | 749,932 | 2.53% | $13.4M | +6% |
| Lane Generational LLC | 444,831 | 1.50% | $7.9M | -9% |
| UBS Group AG | 428,632 | 1.44% | $7.6M | -1% |
| Millennium Management LLC | 357,676 | 1.21% | $6.4M | +54% |
| Brown Advisory Inc | 325,906 | 1.10% | $5.8M | No change |
| Compass Financial Management LLC | 295,680 | 1.00% | $5.3M | – |
| Susquehanna International Group, LLP | 240,282 | 0.81% | $4.3M | +76% |
| Northern Trust Corp | 230,986 | 0.78% | $4.1M | +10% |
| Pier Capital, LLC | 222,761 | 0.75% | $4M | – |
| Vanguard Fiduciary Trust Co | 213,246 | 0.72% | $3.8M | +4% |
| Vanguard Portfolio Management LLC | 194,584 | 0.66% | $3.5M | -32% |
| Tudor Investment Corp Et Al | 173,759 | 0.59% | $3.1M | +11% |
| Morgan Stanley | 165,786 | 0.56% | $3M | +28% |
| Two Sigma Investments, LP | 154,851 | 0.52% | $2.8M | -27% |
| Bank of New York Mellon Corp | 151,767 | 0.51% | $2.7M | +6% |
| Parsons Capital Management Inc | 148,976 | 0.50% | $2.7M | -0% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, CLPT insiders reported $0 of open-market purchases and $2.5M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Joseph Burnett | CEO | Sale | 20,000 | $19.38 | $388K | Form 4 |
| Jun 17, 2026 | Joseph Burnett | CEO | Sale | 1,843 | $17.94 | $33.1K | Form 4 |
| Jun 17, 2026 | Joseph Burnett | CEO | Sale | 60,000 | $17.79 | $1.1M | Form 4 |
| Jun 1, 2026 | Timothy T. Richards | Director | Sale | 5,415 | $12.17 | $65.9K | Form 4 |
| May 21, 2026 | Matthew B. Klein | Director | Sale | 16,000 | $11.59 | $185K | Form 4 |
| May 20, 2026 | Lynnette C Fallon | Director | Sale | 5,091 | $11.14 | $56.7K | Form 4 |
| Feb 25, 2026 | Joseph Burnett | CEO | Sale | 19,951 | $15.17 | $303K | Form 4 |
| Jan 26, 2026 | Joseph Burnett | CEO | Sale | 2,943 | $15.57 | $45.8K | Form 4 |
| Jan 9, 2026 | Joseph Burnett | CEO | Sale | 20,000 | $16.12 | $322K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Joseph Burnett | CEO and President, Director | – | $2.2M | Jun 29, 2026 |
| Matthew B. Klein | Director | – | $185K | May 21, 2026 |
| Timothy T. Richards | Director | – | $65.9K | Jun 1, 2026 |
| Lynnette C Fallon | Director | – | $56.7K | May 20, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
CLPT short interest
High short interest. 13.4% of CLPT shares are sold short: about 1 share in 7. Over the last 12 reports the number of shares short went down 4%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 4.29M CLPT shares were sold short, 13.4% of the shares outstanding, down 7.2% from the report before. At the average daily volume of 654,965 shares, buying them all back would take about 6.6 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 4.29M | 13.40% | -7% | 654,965 | 6.6 |
| Oct 15, 2026 | 4.63M | 15.17% | -3% | 703,203 | 6.6 |
| Sep 30, 2026 | 4.76M | 15.61% | +10% | 792,178 | 6.0 |
| Sep 15, 2026 | 4.33M | 14.19% | +3% | 625,318 | 6.9 |
| Aug 31, 2026 | 4.19M | 13.74% | -7% | 489,940 | 8.6 |
| Aug 14, 2026 | 4.50M | 14.74% | +15% | 762,849 | 5.9 |
| Jul 31, 2026 | 3.89M | 12.77% | +5% | 518,457 | 7.5 |
| Jul 15, 2026 | 3.70M | 12.46% | -14% | 466,107 | 7.9 |
| Jun 30, 2026 | 4.30M | 14.50% | -13% | 1.55M | 2.8 |
| Jun 15, 2026 | 4.92M | 16.58% | +4% | 510,245 | 9.6 |
| May 29, 2026 | 4.74M | 15.98% | +6% | 583,113 | 8.1 |
| May 15, 2026 | 4.49M | 15.13% | -9% | 637,556 | 7.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
ClearPoint Neuro company events
ClearPoint Neuro filed 8 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Oct 28, 2026.
- Oct 28, 2026ResultsReleased financial results. Filing
- Aug 3, 2026ResultsReleased financial results. Filing
- May 21, 2026LeadershipThe annual meeting of the stockholders of ClearPoint Neuro, Inc. was held on May 20, 2026. Filing
- May 13, 2026ResultsReleased financial results. Filing
- Mar 17, 2026ResultsReleased financial results. Filing
- Jan 12, 2026ResultsReleased financial results. Filing
- Jan 5, 2026AgreementAs previously disclosed in the Quarterly Report on Form 10-Q of ClearPoint Neuro, Inc. filed with the Securities and Exchange Commission on November 6, 2025, the Company, CALW SA LLC, as purchaser agent, and TPC Investments III LP, an affiliate of Oberland Capital Management LLC, are parties to a… Filing
- Nov 20, 2025DealIs incorporated by reference into this Item 1.01. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
ClearPoint Neuro financials
Famous investors that hold CLPT
2 of the 50 well-known investors we track reported holding CLPT in their latest 13F filing. The largest position is Israel Englander's, worth $3M.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 241,627 | $3M | 0.0% | -32% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 81,991 | $1M | 0.0% | +68% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named CLPT in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 3, 2026 | BIGGER CAPITAL FUND L P | 13G/A | 5.3% |
| Nov 3, 2026 | BIGGER CAPITAL FUND L P | 13G/A | 5.3% |
Questions about ClearPoint Neuro, Inc. (CLPT) stock
Who owns the most CLPT stock?
The largest reported owner of ClearPoint Neuro, Inc. (CLPT) is BlackRock, Inc., with 8.0% of the company. In total, 129 funds and institutions reported holding CLPT at the end of Q2 2026, together about 47% of the shares. See the largest owners.
Are CLPT insiders buying or selling?
In the last 12 months, CLPT insiders reported no open-market purchases and 9 sales worth $2.5M. The latest trade was on Jun 29, 2026. See every trade.
What is the short interest in CLPT?
As of Oct 30, 2026, 4.29M CLPT shares were sold short, 13.4% of the shares outstanding, down 7.2% from the report before. At the average daily volume of 654,965 shares, buying them all back would take about 6.6 trading days (days to cover). See the history.
Which famous investors hold CLPT?
2 of the 50 well-known investors we track reported CLPT in their latest 13F filing, including Israel Englander, Ken Griffin. The largest position is worth $3M. See all holders.
Executive pay
ClearPoint Neuro's chief executive was paid a total of $2.8M for the year ended Dec 31, 2025, up 11% from $2.5M the year before. In the last 12 months, ClearPoint Neuro's executives and directors bought no stock on the open market and sold $2.5M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.